6901 — Diamond Biofund Share Price
0.000.00%
Last trade - 00:00- TWD19.11bn
- TWD14.10bn
- -TWD2.23bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.83 | ||
| Price to Tang. Book | 1.83 | ||
| Price to Free Cashflow | 16.89 | ||
| Price to Sales | -8.52 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -23.02% | ||
| Return on Equity | -21.67% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | TWDm | 6,501.34 | 3,063.73 | 1,015.63 | -2,439.52 | -2,228.79 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | -53.17 | -72.89 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Diamond Biofund Inc is a Taiwan-based company primarily engaged in the venture capital and general investment industries. The Company focuses on investments in the biotechnology and medical fields. Main investment areas include new drug research and development, high-end medical devices, innovative medical service technologies or models, medical access, and agricultural biotechnology. The Company's investments are primarily in the domestic sector.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- January 9th, 2013
- Public Since
- July 25th, 2022
- No. of Employees
- 33
- Sector
- Investment Banking & Investment Services
- Industry
- Financials
- Exchange
- Taiwan Stock Exchange
- Shares in Issue
- 851,390,000
- Address
- 10F, No.236, Section 4,, TAIPEI, 106
- Web
- https://www.diamondbiofund.com/tc/index.htm
- Phone
- +886 227031338
- Contact
- Youmei Wu
- Auditors
- Deloitte & Touche LLP
Upcoming Events for 6901
Similar to 6901
Capital Futures
Taiwan Stock Exchange
Capital Securities
Taiwan Stock Exchange
China Bills Finance
Taiwan Stock Exchange
IBF Financial Holdings Co
Taiwan Stock Exchange
LINE Pay Taiwan
Taiwan Stock Exchange
FAQ
What is the Diamond Biofund share price?
As of Today at 20:14 UTC, shares in Diamond Biofund are trading at TWD22.30. This share price information is delayed by 15 minutes.
How has the Diamond Biofund share price performed this year?
Shares in Diamond Biofund last closed at TWD22.30 and the price had moved by -43.76% over the past 365 days. In terms of relative price strength the Diamond Biofund share price has underperformed the FTSE Developed Asia Pacific Index by -43.12% over the past year.
What are the analyst and broker recommendations for Diamond Biofund?
There is no consensus recommendation for this security.
Find out moreWhat is the Diamond Biofund dividend yield?
Diamond Biofund does not currently pay a dividend.
Does Diamond Biofund pay a dividend?
Diamond Biofund does not currently pay a dividend.
When does Diamond Biofund next pay dividends?
Diamond Biofund does not currently pay a dividend.
How do I buy Diamond Biofund shares?
To buy shares in Diamond Biofund you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Diamond Biofund?
As of the previous close price of TWD22.30, shares in Diamond Biofund had a market capitalisation of TWD19.11bn.
Where are Diamond Biofund shares listed?
Here are the trading details for Diamond Biofund:
- Country of listing: Taiwan
- Exchange: TAI
- Ticker Symbol: 6901
What kind of share is Diamond Biofund?
Based on an overall assessment of its quality, value and momentum Diamond Biofund is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Diamond Biofund share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Diamond Biofund share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Diamond Biofund. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -37.9%.
As of the last closing price of TWD22.30, shares in Diamond Biofund were trading -36.57% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Diamond Biofund PE Ratio?
The Diamond Biofund PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at TWD22.30.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Diamond Biofund?
We do not have data on Diamond Biofund's directors